Triple-negative breast cancer (TNBC) is a subtype of breast cancer in which the estrogen and the progesterone receptors are not expressed, and the human epidermal growth factor receptor 2 (HER2) is not amplified or overexpressed [2,3,4,5]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.